Power Law company profile

Viridian Therapeutics

Biotech & Life Sciences · Boulder, United States · Founded 2007 · IPO 2017 Unicorn

Focused on the development therapeutics for the treatment of cardiovascular and muscle diseases

Valuation

$655M

Market cap · May/2026

Revenue

$71M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

19 investors on Viridian Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 4 investors entered at this stage

Broadview Ventures

Boulder Ventures

Atlas Venture

Amgen Ventures

Series B+ 15 investors entered at this stage

MRL Ventures

Surveyor Capital

MP Healthcare Venture Management

Perceptive Advisors

Commodore Capital

Brace Pharma

RTW Investments

JAFCO

Paradigm BioCapital

Fidelity Investments

Venrock

Fairmount Funds Management

Remeditex Ventures

Deep Track Capital

Braidwell

Global footprint

Where Viridian Therapeutics has talent and traffic

AI talent share

0.4% of workforce is AI talent
(1 of 278 staff)

Core AI00%

Other AI10.36%

Non-AI workforce27799.64%

Workforce by country

6 countries with
team presence

🇺🇸 United States97.2%

🇫🇷 France0.6%

🇦🇹 Austria0.6%

🇵🇱 Poland0.6%

🇰🇼 Kuwait0.6%

Top 5 of 6 shown

Web traffic by country

12K monthly visits
across markets

🇺🇸 United States76.7%

🇬🇧 United Kingdom12.5%

🇮🇳 India10.8%

🇨🇦 Canada0.8%

Top 4 markets shown

Patent intelligence

$57M patent portfolio · 32 active families

Estimated portfolio value

$57M

8.7% of market cap · 2.9× smaller than top peer Amicus Therapeutics ($164M)

32 active patent families

Where Viridian Therapeutics innovates PharmacologyMedicinal chemistryPharmaceutical medicineDiseasePharmaceutical drug

Where Viridian Therapeutics concentrates vs peers

Each axis is a top-10 topic across Viridian Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Viridian Therapeutics

An AI-synthesized read of the highest-engagement posts about Viridian Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Viridian Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles